Equillium Inc (EQ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $106.20M
Last updated: Nov 17, 2026 at 11:05 AM ET
Equillium Inc (EQ) Earnings: Report Dates and Results
Equillium (EQ) is expected to report earnings on Mar 23, 2027. In the quarter ended Sep 30, 2026, Equillium reported EPS of -$0.04, above the -$0.05 estimate. It beat the EPS estimate in 7 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
EQ has an expected report date of Mar 23, 2027.
Earnings History
Of the 33 quarters below that had an estimate, EQ beat 19 and missed 14. The widest gap in the table came in the quarter ended Dec 31, 2022, when EPS landed 366.67% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.04 | -$0.05 | -$0.06 - -$0.04 | +20.00% | Beat | N/A | 7 | 1 up, 0 down | Nov 12, 2026 | N/A |
| Jun 30, 2026 | -$0.04 | -$0.05 | -$0.10 - -$0.05 | +20.00% | Beat | N/A | 8 | N/A | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$0.06 | -$0.04 | -$0.05 - -$0.04 | -50.00% | Miss | N/A | 5 | N/A | May 13, 2026 | N/A |
| Dec 31, 2025 | -$0.04 | -$0.07 | -$0.08 - -$0.05 | +42.86% | Beat | N/A | 3 | 0 up, 0 down | Mar 25, 2026 | N/A |
| Sep 30, 2025 | -$0.06 | -$0.22 | -$0.22 - -$0.22 | +72.73% | Beat | N/A | 1 | 0 up, 0 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.16 | -$0.18 | -$0.23 - -$0.14 | +11.11% | Beat | -1700.0% | 2 | 0 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$0.24 | -$0.33 | -$0.41 - -$0.26 | +27.27% | Beat | N/A | 2 | 0 up, 0 down | May 14, 2025 | N/A |
| Dec 31, 2024 | -$0.16 | -$0.31 | -$0.35 - -$0.27 | +48.39% | Beat | N/A | 2 | 0 up, 0 down | Mar 27, 2025 | $4.39M |
| Sep 30, 2024 | $0.00 | $0.14 | N/A | -100.14% | Miss | N/A | 3 | 0 up, 1 down | Nov 13, 2024 | $12.16M |
| Jun 30, 2024 | $0.01 | -$0.13 | -$0.22 - -$0.08 | +107.69% | Beat | N/A | 4 | 0 up, 0 down | Aug 8, 2024 | $13.85M |
| Mar 31, 2024 | -$0.08 | -$0.11 | N/A | +27.27% | Beat | N/A | 1 | 0 up, 0 down | May 9, 2024 | $10.69M |
| Dec 31, 2023 | -$0.07 | -$0.17 | N/A | +58.82% | Beat | -187.5% | N/A | 0 up, 0 down | Mar 25, 2024 | $9.21M |
| Sep 30, 2023 | -$0.11 | -$0.12 | N/A | +8.33% | Beat | N/A | 1 | 0 up, 0 down | Nov 8, 2023 | $8.87M |
| Jun 30, 2023 | -$0.10 | -$0.11 | N/A | +9.09% | Beat | N/A | 1 | 0 up, 0 down | Aug 9, 2023 | $9.12M |
| Mar 31, 2023 | -$0.11 | -$0.06 | N/A | -83.33% | Miss | N/A | 1 | 1 up, 0 down | May 11, 2023 | $8.88M |
| Dec 31, 2022 | $0.08 | -$0.03 | N/A | +366.67% | Beat | N/A | 1 | 0 up, 0 down | Mar 23, 2023 | $15.76M |
| Sep 30, 2022 | -$0.40 | -$0.37 | -$0.41 - -$0.02 | -8.11% | Miss | N/A | 3 | 0 up, 0 down | Nov 14, 2022 | N/A |
| Jun 30, 2022 | -$0.41 | -$0.40 | -$0.44 - -$0.38 | -2.50% | Miss | N/A | 4 | 0 up, 0 down | Aug 15, 2022 | N/A |
| Mar 31, 2022 | -$1.17 | -$0.38 | -$0.40 - -$0.35 | -207.89% | Miss | N/A | 4 | 0 up, 0 down | May 12, 2022 | N/A |
| Dec 31, 2021 | -$0.36 | -$0.34 | -$0.40 - -$0.24 | -5.88% | Miss | N/A | 5 | N/A | Mar 23, 2022 | N/A |
| Sep 30, 2021 | -$0.35 | -$0.34 | -$0.36 - -$0.32 | -2.94% | Miss | N/A | 4 | 2 up, 0 down | Nov 10, 2021 | N/A |
| Jun 30, 2021 | -$0.31 | -$0.32 | -$0.34 - -$0.27 | +3.13% | Beat | N/A | 3 | N/A | Aug 10, 2021 | N/A |
| Mar 31, 2021 | -$0.33 | -$0.32 | -$0.38 - -$0.26 | -3.13% | Miss | N/A | 5 | N/A | May 13, 2021 | N/A |
| Dec 31, 2020 | -$0.36 | -$0.40 | -$0.47 - -$0.33 | +10.00% | Beat | N/A | 5 | N/A | Mar 24, 2021 | N/A |
| Sep 30, 2020 | -$0.31 | -$0.44 | -$0.48 - -$0.30 | +29.55% | Beat | N/A | 4 | N/A | Nov 10, 2020 | N/A |
| Jun 30, 2020 | -$0.37 | -$0.44 | -$0.50 - -$0.35 | +15.91% | Beat | N/A | 4 | N/A | Aug 12, 2020 | N/A |
| Mar 31, 2020 | -$0.45 | -$0.41 | -$0.49 - -$0.28 | -9.76% | Miss | N/A | 4 | N/A | May 13, 2020 | N/A |
| Dec 31, 2019 | -$0.44 | -$0.39 | -$0.43 - -$0.35 | -12.82% | Miss | N/A | 4 | N/A | Mar 26, 2020 | N/A |
| Sep 30, 2019 | -$0.35 | -$0.42 | -$0.46 - -$0.35 | +16.67% | Beat | N/A | 3 | N/A | Nov 12, 2019 | N/A |
| Jun 30, 2019 | -$0.35 | -$0.41 | -$0.44 - -$0.21 | +14.63% | Beat | N/A | 4 | N/A | Aug 12, 2019 | N/A |
| Mar 31, 2019 | -$0.34 | -$0.30 | -$0.31 - -$0.30 | -13.33% | Miss | N/A | 2 | N/A | May 13, 2019 | N/A |
| Dec 31, 2018 | -$0.31 | -$0.29 | -$0.36 - -$0.18 | -6.90% | Miss | N/A | 3 | N/A | Mar 27, 2019 | N/A |
| Sep 30, 2018 | -$0.31 | -$0.11 | -$0.11 - -$0.11 | -181.82% | Miss | N/A | 1 | N/A | Oct 12, 2018 | N/A |
| Jun 30, 2018 | -$0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 3, 2018 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.50, after -$0.23 the year before. It was -$0.76 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.50 | N/A |
| Dec 31, 2024 | -$0.23 | N/A |
| Dec 31, 2023 | -$0.39 | N/A |
| Dec 31, 2022 | -$1.90 | N/A |
| Dec 31, 2021 | -$1.35 | N/A |
| Dec 31, 2020 | -$1.49 | N/A |
| Dec 31, 2019 | -$1.48 | N/A |
| Dec 31, 2018 | -$0.76 | N/A |
Frequently Asked Questions About EQ
When is Equillium's next earnings date?
Equillium's next earnings report is expected for Mar 23, 2027.
Did EQ beat earnings estimates last quarter?
Yes. Equillium reported EPS of -$0.04 for the quarter ended Sep 30, 2026, above the -$0.05 estimate, a 20.00% surprise.
What EPS do analysts expect from EQ next quarter?
The consensus EPS estimate for Equillium for the quarter ending Dec 31, 2026 is -$0.06 from 13 analysts, with estimates from -$0.07 to -$0.03.
How often does EQ beat earnings estimates?
Equillium beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +24.04%.
EQ pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors